开发和评估基于质母细胞瘤同源A2b1111的IL13RA2向药物递送系统
Liwen Chen1,2, Chao Shang1, Yang Hong2
1Department of Neurobiology, School of Life Sciences, China Medical University, Shenyang, Liaoning, 110022, China.
Materials today. Bio
|February 2, 2026
概括
这项研究开发了一种使用A2b11来治疗质母细胞瘤 (GBM) 的向脂质体药物递送系统. A2b11-脂质体显示出增强的GBM细胞积累和抗瘤作用,为脑瘤提供了一个有前途的新疗法.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 质母细胞瘤 (GBM) 是一种具有有限治疗选择的侵袭性脑瘤.
- 目前的疗法因药物输送不良,瘤积累较低和毒性而受到影响.
- 需要有针对性的药物输送系统来提高GBM治疗疗效.
研究的目的:
- 设计和评估一种针对质母细胞瘤的新型向药物递送平台.
- 使用针对IL13RA2抗原的A2b11来增强GBM细胞结合.
- 评估装载有治疗剂的A2b11修饰脂质体的体外和体内疗效.
主要方法:
- 用A2b11修改了脂质体,以向表达IL13RA2.2的GBM细胞.
- A2b11-脂质体中含有化 (FLA) 用于跟踪和temozolomide (TLA) 用于治疗.
- 在体外研究中评估了细胞积累和抗GBM功效.
- 在体内研究中使用异种移植小鼠模型来评估安全性,生物分布和抗瘤作用.
主要成果:
- 与未经修改的脂质体相比,A2b11修改的脂质体在GBM细胞中的积累显著增加.
- 在体内研究表明,瘤部位的高FLA积累具有良好的生物相容性和安全性.
- 装有TLA的A2b11脂质体有效诱导了质母细胞细胞灭绝,并抑制了瘤血管生成.
- 向的脂质体系统显著抑制了GBM瘤的生长.
结论:
- A2b11改性脂质体系统是针对性质母细胞瘤治疗的一个有前途的平台.
- 这种方法可以提高药物输送的精度和有效性,同时最大限度地降低毒性.
- 进一步的开发可能会导致未来的临床应用,用于治疗侵略性脑瘤.
相关概念视频
Drug Delivery: Overview
852
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
852
Drug Delivery: Enteral Route
1.8K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.8K
Drug Delivery: Parenteral Route
1.7K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.7K
Targets for Drug Action: Overview
10.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.3K
Peptide Bonds
83.0K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.0K
Drug Delivery: Miscellaneous Routes
818
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
818


